Now showing items 1-2 of 2
Big Pharma's internationalization of R&D to China
(Taylor & Francis, 2015-04-18)
China's increasing integration into the global pharmaceutical value chain is occurring at a time when big pharma's traditional R&D model has entered a period of crisis, and when China faces significant challenges in providing ...
Foreign R&D in China: An evolving innovation landscape
(Edward Elgar, 2014)
[No abstract available]